Growth Metrics

Eli Lilly (LLY) FCF Payout Ratio Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.48%
Dec 31, 2025 32.15%
Sep 30, 2025 -15.95%
Jun 30, 2025 26.06%
Mar 31, 2025 9.79%
Dec 31, 2024 27.20%
Sep 30, 2024 1.02%
Jun 30, 2024 27.31%
Mar 31, 2024 1.90%
Dec 31, 2023 -27.39%
Sep 30, 2023 21.94%
Jun 30, 2023 -111.06%
Mar 31, 2023 -20.08%
Dec 31, 2022 12.53%
Sep 30, 2022 10.53%
Jun 30, 2022 41.46%
Mar 31, 2022 -33.70%
Dec 31, 2021 2.98%
Sep 30, 2021 9.67%
Jun 30, 2021 18.78%
Mar 31, 2021 18.98%
Dec 31, 2020 -10.96%
Sep 30, 2020 -5.58%
Jun 30, 2020 -16.38%
Mar 31, 2020 36.86%
Dec 31, 2019 -6.76%
Sep 30, 2019 4.59%
Jun 30, 2019 17.10%
Mar 31, 2019 -4.50%
Dec 31, 2018 6.06%
Sep 30, 2018 0.36%
Jun 30, 2018 6.20%
Mar 31, 2018 4.14%
Dec 31, 2017 -1.74%
Sep 30, 2017 -3.50%
Jun 30, 2017 -4.71%
Mar 31, 2017 33.53%
Dec 31, 2016 1.02%
Sep 30, 2016 5.64%
Jun 30, 2016 10.01%
Mar 31, 2016 -37.15%
Dec 31, 2015 26.17%
Sep 30, 2015 13.12%
Jun 30, 2015 19.52%
Mar 31, 2015 -37.88%
Dec 31, 2014 10.68%
Sep 30, 2014 -4.51%
Jun 30, 2014 -1.80%
Mar 31, 2014 24.24%